Hereditary Eye Disease Study


About this study

The purpose of this study is to learn more about eye diseases that run in families.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subjects with hereditary eye disease.
  • Subjects with a family history of hereditary eye disease.
  • Subjects without hereditary eye disease and no family history of hereditary eye disease who would serve as a control in specific case-control experiments.
  • Ability to understand and willingness to sign the informed consent documents.

Exclusion Criteria:

  • Unable or unwilling to sign or understand the informed consent documents.
  • Unwilling to participate in the research.
  • Unwilling to allow genetic testing.
  • Unwilling to allow samples to be sent to other institutional for testing.
  • Not meeting the inclusion criteria.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Keith Baratz, M.D.

Open for enrollment

Contact information:

Emily Treichel

(507) 284-8558

More information


Publications are currently not available

Mayo Clinic Footer